Hem › Juvenil artrit › Texas
Kliniska studier för Juvenil artrit i Texas
4 studier för Juvenil artrit söker deltagare vid platser i Texas.
Officiell studietext (engelska)
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Texas Arthritis Center, El Paso
RekryterarFas 1
Ålder 2 till 17 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06751238A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
RekryterarFas 3
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Child Neurology Consultants of Austin /ID# 260562, Austin
RekryterarFas 3
Ålder 5 till 17 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of Texas Southwestern Medical Center Dallas, Dallas
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RekryterarObservationsstudie
Upp till ålder 21 · Alla kön · Uppdaterad 27 aug. 2026 · NCT02418442Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.